| Income Statement |
| Total Revenue | 752.75M |
|
| Revenues (USD) | 752.75M |
| Cost of Revenue | 267.56M |
| Gross Profit | 485.19M |
| Operating Expenses | 560.98M |
| Research and Development Expense | 228.07M |
| Selling, General and Administrative Expense | 327.20M |
| Operating Income | -75.79M |
| Interest Expense | 890.00K |
| Income Tax Expense | -261.00K |
| Net Income | -66.97M |
| Net Income Common Stock | -66.97M |
| Net Income Common Stock (USD) | -66.97M |
| Consolidated Income | -66.97M |
| Earnings per Basic Share | -0.47 |
| Earnings per Basic Share (USD) | -0.47 |
| Earnings per Diluted Share | -0.47 |
| Earning Before Interest & Taxes (EBIT) | -66.34M |
| Earning Before Interest & Taxes (USD) | -66.34M |
| Weighted Average Shares | 143.28M |
| Weighted Average Shares Diluted | 143.28M |
| Balance Sheet |
| Cash and Equivalents | 1.09B |
| Cash and Equivalents (USD) | 1.09B |
| Trade and Non-Trade Receivables | 421.97M |
| Current Assets | 1.66B |
| Property, Plant & Equipment Net | 447.26M |
| Total Assets | 2.66B |
| Debt Current | 80.29M |
| Total Debt | 223.37M |
| Current Liabilities | 553.20M |
| Debt Non-Current | 143.07M |
| Total Liabilities | 836.00M |
| Accumulated Retained Earnings (Deficit) | -2.93B |
| Accumulated Other Comprehensive Income | -108.00K |
| Shareholders Equity | 1.82B |
| Shareholders Equity (USD) | 1.82B |
| Assets Non-Current | 998.55M |
| Total Debt (USD) | 223.37M |
| Deferred Revenue | 56.64M |
| Goodwill and Intangible Assets | 501.30M |
| Inventory | 80.35M |
| Liabilities Non-Current | 282.80M |
| Trade and Non-Trade Payables | 75.15M |
| Tax Liabilities | 701.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 28.60M |
| Net Cash Flow from Financing | 12.21M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.57M |
| Capital Expenditure | -63.43M |
| Issuance (Purchase) of Equity Shares | 17.30M |
| Net Cash Flow from Investing | -63.43M |
| Net Cash Flow from Operations | 54.79M |
| Share Based Compensation | 103.10M |